BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

AI Briefing

• – BioHarvest Sciences signs $1.2M CDMO Stage 2 contract for a rare fragrance development
• – Company to utilize its proprietary Botanical Synthesis platform
• – Deal further demonstrates growing demand for sustainable, plant-based molecule development